STEPANKOVA, Lenka, Eva KRALIKOVA, Kamila ZVOLSKA, Alexandra PANKOVA, Petra OVESNÁ, Milan BLAHA and Leonie S. BROSE. Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up. ANNALS OF BEHAVIORAL MEDICINE. New York: Springer, vol. 51, No 3, p. 454-463. ISSN 0883-6612. doi:10.1007/s12160-016-9869-6. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up
Authors STEPANKOVA, Lenka (203 Czech Republic), Eva KRALIKOVA (203 Czech Republic), Kamila ZVOLSKA (203 Czech Republic), Alexandra PANKOVA (203 Czech Republic), Petra OVESNÁ (203 Czech Republic, guarantor, belonging to the institution), Milan BLAHA (203 Czech Republic, belonging to the institution) and Leonie S. BROSE (826 United Kingdom of Great Britain and Northern Ireland).
Edition ANNALS OF BEHAVIORAL MEDICINE, New York, Springer, 2017, 0883-6612.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 50101 Psychology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.118
RIV identification code RIV/00216224:14110/17:00096930
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s12160-016-9869-6
UT WoS 000401922100013
Keywords in English Smoking cessation; Depression; Cohort study; Preventive health services; Effectiveness; Evidence-based practice
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 12:14.
Abstract
Smoking is more prevalent among people with depression. Depression may make cessation more difficult and cessation may affect depression symptoms. The aims of this study were to assess the associations between (1) baseline depression and 1-year smoking abstinence and (2) abstinence and change in depression. Observational study using data collected routinely in a smoking cessation clinic in the Czech Republic from 2008 to 2014. Aim 1: N = 3775 patients; 14.3% reported mild and 15.4% moderate/severe baseline depression levels measured using Beck's Depression Inventory (BDI-II). Logistic regressions assessed if depression level predicted 1-year biochemically verified abstinence while adjusting for patient and treatment characteristics. Aim 2: N = 835 patients abstinent at 1 year; change in depression was analysed using Chi-square statistics, t test and mixed method analyses of variance. Rate of abstinence was lower for patients with mild (32.5%, OR = 0.68; 95% CI: 0.54 to 0.87, p = 0.002) and moderate/severe depression (25.8%; OR = 0.57, 95% CI: 0.45 to 0.74, p < 0.001) compared with patients without depression (40.5%). Across abstinent patients, the majority with baseline depression reported lower depression levels at follow-up. Overall mean (SD) BDI-II scores improved from 9.2 (8.6) to 5.3 (6.1); t(834) = 14.6, p < 0.001. There were significant main effects of time (F(1832) = 880.8, p < 0.001, partial eta(2) = 0.51) and baseline depression level (F(2832) = 666.4, p < 0.001, partial eta(2) = 0.62) on follow-up depression and a significant depression * time interaction (F(2832) = 296.5, p < 0.001, partial eta(2) = 0.42). In this effective smoking cessation clinic, depression at the start of treatment predicted reduced smoking abstinence 1 year later. Patients abstinent from smoking experienced considerable improvement in depression.
PrintDisplayed: 20/4/2024 03:18